India Launches Mounjaro – The First-Ever Weight-Loss Injection for Obesity!
Tirzepatide (Mounjaro) is a breakthrough GIP & GLP-1 receptor agonist.
Originally used for Type 2 Diabetes, Mounjaro is now approved for weight loss in obese and overweight adults.
Weekly injectable formulation
Targets appetite, slows digestion, and promotes fullness
Shown to reduce up to 22% of body weight in global trials.
4 Likes
Thanks
1 Like
There is a chances that clotrimazole which is used in the treatment of fungal infections might be useful in eliminating cancer cells